+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Short and long term outcome of Helicobacter pylori positive resistant duodenal ulcers treated with colloidal bismuth subcitrate plus antibiotics or sucralphate alone



Short and long term outcome of Helicobacter pylori positive resistant duodenal ulcers treated with colloidal bismuth subcitrate plus antibiotics or sucralphate alone



Gut 34(4): 466-469



Thirty two patients with Helicobacter pylori positive duodenal ulcers resistant to treatment were randomly assigned to 4 weeks' treatment with sucralphate 4 g/day or colloidal bismuth subcitrate 480 mg/day plus amoxycillin from days 1 to 7 and tinidazole from days 8 to 14. After 4 weeks, patients with unhealed ulcers were crossed over to the other form of treatment for a further 4 week period. Patients with healed ulcers were followed up for 1 year without maintenance therapy with clinical and endoscopic investigations 3, 6, and 12 months after healing. Complete healing rates at 4 weeks were 88% (15 of 17) in the colloidal bismuth subcitrate plus antibiotics group and 40% (six of 15) in the sucralphate group (p lt 0.05). After cross over, overall healing rates were 88% (22 of 25) and 47% (eight of 17), respectively (p lt 0.05). H pylori eradication occurred in 83% of patients treated with the triple therapy. Cumulative relapse rates at 12 months were 12% (two of 17) in patients in whom H pylori had been eradicated and 100% (10 of 10) in those with persistent infection after short term therapy (p lt 0.05). These results show that a colloidal bismuth subcitrate plus antibiotics regimen is highly effective in the short term treatment of resistant duodenal ulcers and that H pylori eradication can change the natural tendency to early recurrence of these ulcers.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 002492108

Download citation: RISBibTeXText

PMID: 8491391


Related references

Short and long term outcome of Helicobacter pylori positive resistant duodenal ulcers treated with colloidal bismuth subcitrate plus antibiotics or sucralfate alone. Gut 34(4): 466-469, 1993

Short and long term outcome of hp positive resistant duodenal ulcers treated with colloidal bismuth subcitrate cbs plus antibiotics or sucralfate. Gastroenterology 102(4 Part 2): A142, 1992

Colloidal bismuth pectin: an alternative to bismuth subcitrate for the treatment of Helicobacter pylori--positive duodenal ulcer. Helicobacter 4(2): 128-134, 1999

Omeprazole and colloidal bismuth subcitrate plus or minus adjuvant antibiotics in the treatment of helicobacter pylori associated duodenal ulcer disease. Gastroenterology 100(5 Part 2): A48, 1991

Treatment of patients with duodenal ulcer positive for Helicobacter pylori infection: Ranitidine or omeprazole associated with colloidal bismuth subcitrate plus amoxicillin. Current Therapeutic Research 57(3): 168-174, 1996

Impact of Colloidal Bismuth Subcitrate in the Eradication Rates of Helicobacter pylori Infection-Associated Duodenal Ulcer Using a Short Treatment Regimen with Omeprazole and Clarithromycin: A Randomized Study. American Journal of Gastroenterology 90(5): 718-721, 1995

Helicobacter pylori gastritis in dyspeptic children. A long-term follow-up after treatment with colloidal bismuth subcitrate and tinidazole. Scandinavian Journal of Gastroenterology 29(3): 203-208, 1994

Bismuth-based quadruple therapy with colloidal bismuth subcitrate + tetracycline + metronidazole + omeprazole in eradication of M sensitive and M resistant Helicobacter pylori. Gastroenterology 116(4 Part 2): A227, 1999

Comparison of colloidal bismuth subcitrate with ranitidine in healing and relapse of Campylobacter pylori-associated duodenal ulcers. Zhonghua Nei Ke Za Zhi 29(6): 339-41 382, 1990

Combined furazolidone and colloidal bismuth subcitrate in the treatment of Helicobacter pylori associated gastritis and duodenal ulcer. Journal of Gastroenterology & Hepatology 11(Suppl. 1): A36, 1996

Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate. Gut 31(9): 999, 1990

Treatment of helicobacter pylori associated non ulcer dyspepsia with combination therapy of colloidal bismuth subcitrate and antibiotics. Gastroenterology 100(5 Part 2): A72, 1991

Combined therapy of duodenal ulcer associated with Helicobacter pylori with electromagnetic decimeter waves and colloidal bismuth subcitrate. Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury .(6): 19-22, 1993

Colloidal bismuth subcitrate impedes proton entry into Helicobacter pylori and increases the efficacy of growth-dependent antibiotics. Alimentary Pharmacology and Therapeutics 42(7): 922-933, 2015

Colloidal bismuth subcitrate is necessary in one week therapy with omeprazole and clarithromycin in the treatment of Helicobacter pylori associated duodenal ulcer randomized study. Gastroenterology 106(4 Suppl. ): A77, 1994